DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,565 filers reported holding DANAHER CORPORATION in Q2 2020. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $215,847 | +3.4% | 870 | 0.0% | 0.12% | +17.9% |
| Q2 2023 | $208,800 | -4.8% | 870 | 0.0% | 0.11% | -10.9% |
| Q1 2023 | $219,275 | +94824.2% | 870 | 0.0% | 0.12% | -7.0% |
| Q4 2022 | $231 | -99.9% | 870 | 0.0% | 0.13% | -6.6% |
| Q3 2022 | $225,000 | -36.4% | 870 | -37.6% | 0.14% | -32.8% |
| Q2 2022 | $354,000 | -13.4% | 1,395 | 0.0% | 0.20% | -1.0% |
| Q1 2022 | $409,000 | -10.9% | 1,395 | 0.0% | 0.21% | -11.2% |
| Q4 2021 | $459,000 | +7.2% | 1,395 | -0.7% | 0.23% | -0.9% |
| Q3 2021 | $428,000 | +13.5% | 1,405 | 0.0% | 0.23% | +18.8% |
| Q2 2021 | $377,000 | +19.3% | 1,405 | 0.0% | 0.20% | +12.6% |
| Q1 2021 | $316,000 | +1.3% | 1,405 | 0.0% | 0.18% | -5.4% |
| Q4 2020 | $312,000 | +2.3% | 1,405 | -0.7% | 0.18% | -10.2% |
| Q3 2020 | $305,000 | +22.0% | 1,415 | 0.0% | 0.21% | +11.4% |
| Q2 2020 | $250,000 | +14.7% | 1,415 | -10.3% | 0.18% | -4.6% |
| Q1 2020 | $218,000 | -28.3% | 1,578 | -20.2% | 0.19% | -9.8% |
| Q4 2019 | $304,000 | +6.3% | 1,978 | 0.0% | 0.22% | -0.9% |
| Q3 2019 | $286,000 | +1.1% | 1,978 | 0.0% | 0.22% | 0.0% |
| Q2 2019 | $283,000 | +5.6% | 1,978 | -2.5% | 0.22% | +3.3% |
| Q1 2019 | $268,000 | +28.2% | 2,028 | 0.0% | 0.21% | +18.0% |
| Q4 2018 | $209,000 | -5.0% | 2,028 | 0.0% | 0.18% | 0.0% |
| Q3 2018 | $220,000 | +5.8% | 2,028 | -3.6% | 0.18% | +8.5% |
| Q2 2018 | $208,000 | +1.0% | 2,103 | 0.0% | 0.16% | -3.5% |
| Q1 2018 | $206,000 | +5.6% | 2,103 | 0.0% | 0.17% | +10.4% |
| Q4 2017 | $195,000 | +8.3% | 2,103 | 0.0% | 0.15% | +4.8% |
| Q3 2017 | $180,000 | +1.7% | 2,103 | 0.0% | 0.15% | -2.0% |
| Q2 2017 | $177,000 | -1.7% | 2,103 | 0.0% | 0.15% | -4.5% |
| Q1 2017 | $180,000 | +9.8% | 2,103 | 0.0% | 0.16% | +11.3% |
| Q4 2016 | $164,000 | – | 2,103 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |